Article: Guy Van Meter Joins Adimab, Inc. as Senior Director, Head of Business Development.

LEBANON, N.H. -- Adimab, Inc., a biotechnology company developing an integrated yeast-based antibody discovery and maturation platform, today announced the appointment of Guy Van Meter as Senior Director, Head of Business Development. Mr. Van Meter comes to Adimab from a business development role at Pfizer Inc, where he was involved in new business initiatives around RNAi therapeutics and regenerative medicine for Pfizer's Biotherapeutics and Bioinnovation Center in San Francisco.

Prior to Pfizer, Mr. Van Meter spent 6 years in business development at Dyax Corp, including managing Dyax's successful phage display licensing program. At Dyax, he established more ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!